1,556 results on '"Yamagata, Kunihiro"'
Search Results
2. Associations of anaemia and iron deficiency with health-related quality of life in patients with chronic kidney disease stage G3b-5 in Japan: sub analysis of the Reach-J CKD cohort study
3. Physical activity and renal outcome in diabetic and non-diabetic patients with chronic kidney disease stage G3b to G5
4. Effective method for life-style modifications focused on dietary sodium intake in chronic kidney disease: sub-analysis of the FROM-J study
5. Evaluating the associations between compliance with CKD guideline component metrics and renal outcomes
6. Exercise instruction during haemodialysis treatment after changes to the insurance regime: a nationwide questionnaire survey in Japan
7. NT-pro BNP level at dialysis initiation is a useful biomarker for predicting hospitalization for ischemic heart disease
8. Synergistic effect of proteinuria on dipstick hematuria-related decline in kidney function: The Japan Specific Health Checkups (J-SHC) Study
9. Relationship between the lower limit of systolic blood pressure target and kidney function decline in advanced chronic kidney disease: an instrumental variable analysis from the REACH-J CKD cohort study
10. Trace proteinuria detected via dipstick test is associated with kidney function decline and new-onset overt proteinuria: the Japan Specific Health Checkups (J-SHC) Study
11. All reported non-canonical splice site variants in GLA cause aberrant splicing
12. Symptom Burden and Its Impact on Quality of Life in Patients With Moderate to Severe CKD: The International Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps)
13. Quantification of escape from X chromosome inactivation with single-cell omics data reveals heterogeneity across cell types and tissues
14. Elevated urinary angiotensinogen excretion links central and renal hemodynamic alterations
15. Association between height loss and mortality in the general population
16. The effect of lifestyle on the mortality associated with respiratory diseases in the general population
17. Health-related Quality of Life in 10 years Long-term Survivors of Chronic Kidney Disease: A From-J Study
18. Estimated Proximal Tubule Fluid Phosphate Concentration and Renal Tubular Damage Biomarkers in Early Stages of Chronic Kidney Disease
19. Carbon footprints by stage of chronic kidney disease: The case of Japan
20. CKD-Associated Pruritus and Clinical Outcomes in Nondialysis CKD
21. Aberrant splicing caused by exonic single nucleotide variants positioned 2nd or 3rd to the last nucleotide in the COL4A5 gene
22. Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS)
23. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
24. The efficacy and safety of mizoribine for maintenance therapy in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: the usefulness of serum mizoribine monitoring
25. DOCK2 is involved in the host genetics and biology of severe COVID-19
26. A nationwide analysis of renal and patient outcomes for adults with lupus nephritis in Japan
27. Nephrology Research in the NDB
28. DC-COX: Data collaboration Cox proportional hazards model for privacy-preserving survival analysis on multiple parties
29. Cerebral and renal hemodynamics: similarities, differences, and associations with chronic kidney disease and aortic hemodynamics
30. Sedentary behavior is associated with reduced cardiovagal baroreflex sensitivity in healthy adults
31. Monthly trends and seasonality of hemodialysis treatment and outcomes of newly initiated patients from the national database (NDB) of Japan
32. Behaviour modification intervention for patients with chronic kidney disease could provide a mid- to long-term reduction in public health care expenditure: budget impact analysis
33. Constipation and risk of death and cardiovascular events.
34. Association of circulating calciprotein particle levels with skeletal muscle mass and strength in middle-aged and older adults
35. Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study
36. Cost-effectiveness of mass screening for dipstick hematuria in Japan
37. Epidemiology and temporal changes in the prognosis of rapidly progressive glomerulonephritis in Japan: a nationwide 1989–2015 survey
38. Prediction of mortality risk of health checkup participants using machine learning-based models: the J-SHC study
39. Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study
40. Health-related behavioral changes and incidence of chronic kidney disease: The Japan Specific Health Checkups (J-SHC) Study
41. The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force
42. Study protocol and baseline characteristics of newly induced dialysis patients: a prospective multi-center cohort study with a biological sample bank, the Ibaraki Dialysis Initiation Cohort (iDIC) study
43. Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease
44. External Validation of a Limited Sampling Strategy for the Estimation of Mycophenolic Acid Exposure Between Different Assay Methods: PETINIA and HPLC Methods.
45. Potential Surrogate Outcomes for Kidney Failure in Advanced CKD: Evaluation of Power and Predictive Ability in CKDopps
46. Circulating fibroblast growth factor 21 links hemodynamics with kidney function in middle-aged and older adults: A mediation analysis
47. The distribution of eGFR by age in a community-based healthy population: the Japan specific health checkups study (J-SHC study)
48. Weight loss reduces the incidence of dipstick proteinuria: a cohort study from the Japanese general population
49. Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease
50. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.